[1] 默沙东中国.https://mp.weixin.qq.com/s/QvbhReleMysNrqgDXXZw_g
[2] 各品牌人乳头瘤病毒(HPV)疫苗说明书
[3] 人乳头瘤病毒疫苗临床应用中国专家共识[J]. 中国妇产科临床杂志, 2021.
[4] LI K, LI Q, SONG L, et al. The distribution and prevalence of human papillomavirus in women in mainland of China[J]. Cancer, 2019, 125(7):1030-1037.
[5] https://www./doi/full/10.1080/21645515.2022.2052700
[6] https://www./journals/lanonc/article/PIIS1470-2045(20)30524-6/fulltext
[7] David MP, Van Herck K, Hardt K, et al. Long-term persistence of anti-HPV- 16 and -18 antibodies induced by vaccination with the AS04-adjuvanted cervical cancer vaccine: modeling of sustained antibody responses. Gynecologic oncology 2009; 115(3 Suppl): S1-6.
[8] Aregay M, Shkedy Z, Molenberghs G, David MP, Tibaldi F. Model-based estimates of long-term persistence of induced HPV antibodies: a flexible subjectspecific approach. Journal of biopharmaceutical statistics 2013; 23(6): 1228-48